Breast cancer

CYP19 gene polymorphisms and the susceptibility to breast cancer in Xinjiang Uigur women

L. Yang, Wang, X. Y., Li, Y. T., Wang, H. L., Wu, T., Wang, B., Zhao, Q., Jinsihan, D., and Zhu, L. P., CYP19 gene polymorphisms and the susceptibility to breast cancer in Xinjiang Uigur women, vol. 14, pp. 8473-8482, 2015.

In this study, the relationship between CYP19 gene polymorphisms and breast cancer in Xinjiang Uigur women was investigated. A case-control study was designed to compare 112 Uigur breast cancer patients with 139 Uigur healthy controls. Individuals were genotyped for the CYP19 rs10046 polymorphism using polymerase chain reaction restriction fragment length polymorphism (PCR-RFLP). Accordingly, the relationship between the rs10046 polymorphism and the susceptibility of Xinjiang Uigur women to breast cancer was analyzed.

Vascular endothelial growth factor +405G/C and -2578C/A polymorphisms and breast cancer risk: a meta-analysis

Y. Zhang, Yu, Y. F., Wang, J. Z., and Jia, H., Vascular endothelial growth factor +405G/C and -2578C/A polymorphisms and breast cancer risk: a meta-analysis, vol. 14, pp. 8909-8918, 2015.

This study aimed to analyze the association between the 405G/C and -2578C/A polymorphisms of the vascular endothelial growth factor (VEGF) gene and breast cancer risk by meta-analysis. A systematic computerized search of PubMed, Google Scholar, and Web of Science databases was performed to identify relevant publications. After rigorous searching and screening, 9 eligible case-control studies were included in this meta-analysis.

Subscribe to Breast cancer